Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 90,322 | 82,422 | 80,297 | 75,592 | 72,864 |
| Cost of Goods | 29,688 | 26,229 | 46,104 | 26,008 | 25,030 |
| Gross Profit | 60,634 | 56,193 | 34,193 | 49,584 | 47,834 |
| Operating Expenses | 69,373 | 66,920 | 39,717 | 59,272 | 58,597 |
| Operating Income | -8,051 | -10,498 | -5,420 | -9,680 | -10,733 |
| Other Income | -226 | 2,407 | 1,979 | 805 | 1,086 |
| Pre-tax Income | -8,277 | -8,091 | -3,441 | -8,875 | -9,647 |
| Income Tax | 125 | N/A | 403 | -152 | -115 |
| Net Income Continuous | -8,402 | -8,091 | -3,844 | -8,723 | -9,532 |
| Net Income | $-8,402 | $-8,091 | $-3,844 | $-8,723 | $-9,532 |
| EPS Basic Total Ops | -0.12 | -0.11 | -0.06 | -0.12 | -0.13 |
| EPS Basic Continuous Ops | -0.12 | -0.11 | -0.05 | -0.12 | -0.13 |
| EPS Diluted Total Ops | -0.12 | -0.11 | -0.06 | -0.12 | -0.13 |
| EPS Diluted Continuous Ops | -0.12 | -0.11 | -0.05 | -0.12 | -0.13 |
| EBITDA(a) | $-1,192 | $-3,828 | $1,136 | $-3,356 | $-4,241 |